SANGAMO THERAPEUTICS, INC Business Operations Contracts & Agreements
19 Contracts & Agreements
- Agency Agreements (1 contract)
- Collaboration Agreements (12)
- Development Agreements (2)
- Indemnification Agreements (1)
- Sales Agreements (2)
- Termination Agreements (1)
- Amendment No. 2 to Research Collaboration and License Agreement between the Company and Pfizer Inc., dated July 21, 2020 (Filed With SEC on November 4, 2020)
- Collaboration and License (Filed With SEC on November 4, 2020)
- Collaboration and License Agreement among the Company, Biogen MA, Inc. and Biogen International GmbH, dated February 26, 2020 (Filed With SEC on May 11, 2020)
- Letter Amendment, dated December 17, 2019, to the Collaboration and License Agreement between the Company and Pfizer Inc., dated May 10, 2017 (Filed With SEC on February 28, 2020)
- Amended and Restated Collaboration and License Agreement between the Company and Kite Pharma, Inc., dated as of September 11, 2019 (Filed With SEC on November 6, 2019)
- Amendment No. 1 to Research Collaboration and License Agreement between the Company and Pfizer., dated December 27, 2017, dated as of March 21, 2019 (Filed With SEC on May 8, 2019)
- Collaboration and License Agreement between the Company and Kite Pharma, Inc., dated February 20, 2018 (Filed With SEC on May 10, 2018)
- Research Collaboration and License Agreement between the Company and Pfizer Inc., dated December 28, 2017 (Filed With SEC on March 1, 2018)
- Collaboration and License Agreement between Sangamo Therapeutics, Inc. and Pfizer, Inc., dated May 10, 2017 (Filed With SEC on August 9, 2017)
- SANGAMO THERAPEUTICS, INC. AMENDED AND RESTATED AT-THE-MARKET OFFERING PROGRAM SALES AGREEMENT (Filed With SEC on May 26, 2017)
- SANGAMO BIOSCIENCES, INC. AT-THE-MARKET OFFERING PROGRAM SALES AGREEMENT (Filed With SEC on December 7, 2016)
- Exhibit A 2016 BT Development Plan [***] (Filed With SEC on February 18, 2016)
- AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT Between SANGAMO BIOSCIENCES, INC. And SHIRE INTERNATIONAL GMBH *** CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH... (Filed With SEC on October 30, 2015)
- INDEMNIFICATION AGREEMENT (Filed With SEC on August 6, 2015)
- RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between Sangamo BioSciences, Inc. and Juvenile Diabetes Research Foundation International Table of Contents (Filed With SEC on April 28, 2015)
- GLOBAL RESEARCH, DEVELOPMENT AND COMMERCIALIZATION COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 7, 2014)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on February 23, 2012)
- Placement Agency Agreement dated July 16, 2007 between Sangamo BioSciences, Inc. and JMP Securities, Piper Jaffray & Co., Leerink Swann & Company and Janney Montgomery Scott LLC (Filed With SEC on July 17, 2007)
- TERMINATION OF SUBSCRIPTION AGREEMENT (Filed With SEC on November 18, 2005)
